By Jeff Overley ( March 4, 2014, 8:17 PM EST) -- The U.S. Food and Drug Administration on Tuesday finalized guidance describing the types of low-risk drug manufacturing changes that only need to be reported annually, backing away from a few proposals that companies deemed burdensome but declining for now to consolidate scattered policies on the subject....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.